Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
24 hedge funds and large institutions have $4.54M invested in Vaccinex, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
63% more capital invested
Capital invested by funds: $2.79M → $4.54M (+$1.75M)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
8% less funds holding
Funds holding: 26 → 24 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
36% less call options, than puts
Call options by funds: $514K | Put options by funds: $809K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$996K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$897K |
| 3 |
State Street
Boston,
Massachusetts
|
+$169K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.8K |
| 5 |
BlackRock
New York
|
+$75.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$161K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$129K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$122K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$62.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$56.1K |
VCNX Hedge Fund Activity: Q2 2021 in Review
24 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q2 2021, worth a combined $4.54M — up 63% from $2.79M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VCNX and 4 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $996K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $161K sold.
- 24 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q2 2021, down from 26 in Q1 2021.
- Funds reported $4.54M of Vaccinex, Inc. Common Stock stock for Q2 2021, up 63% quarter-over-quarter.
- 4 funds opened new Vaccinex, Inc. Common Stock positions in Q2 2021 and 6 closed out, a net change of -2 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q2 2021 was Point72 Asset Management, an estimated $996K added.
- The largest Vaccinex, Inc. Common Stock seller in Q2 2021 was Tower Research Capital (TRC), an estimated $161K sold.
Based on aggregated 13F filings for Q2 2021.